Kevin Niswender, MD, PhD, whose work has helped advance understanding of the neural underpinnings of obesity and metabol...
Carrick Therapeutics, a biopharmaceutical company focusing on the innovative research and development of transformative ...
U.S. based Acorda Therapeutics Inc. suffered a rapid decrease by a record 40 percent after patients died in final-s...
Singapore - Global Gene Corp (UK based genomics data platform and applications company) announced a collaboration with T...
Singapore – Researchers from Duke-NUS Medical School (Duke-NUS) and the National Heart Centre Singapore ...
The Aerobika device (Trudell Medical International) is a cost-effective treatment option in the management of COPD exace...
Sanofi has decided to walk away from the Parkinson’s gene therapy covered by its $845 million alliance with V...
Singapore – Bone marrow contains hematopoietic stem cells, the precursors to every blood cell type. These cells sp...
Singapore – Thousands of preterm babies could be saved by waiting 60 seconds before clamping the umbilical cord af...
Singapore - In a study in Science, researchers at Albert Einstein College of Medicine, part of Montefiore Medicine, repo...
Singapore - Our brains wire themselves up during development according to a series of remarkable genetic programs that h...
TB Alliance recently announced that TBA-7371 and sutezolid entered phase 1 clinical trials. Both compounds have proceede...
A DNA-based Zika vaccine from Inovio Pharmaceuticals Inc and South Korea’s GeneOne Life Science induced anti-Zika ...
Advanced Bifurcation Systems (ABS or the Company), a clinical stage medical device company developing an innovative sten...
Clinical trials researching cancer therapies should be more inclusive of a broader range of patients, according to the A...
The U.S. National Institutes of Health (NIH) plans to enforce the new rules which are based on a revised definition of &...
A newly-developed drug which has recently been approved for use in Singapore may aid in the fight against cholesterol. ...
French biotech firm Cellectis has revealed that the Food and Drug Administration has put a clinical holdon two of its cl...
